Skip to main content
PMC home page
Molecular Medicine logoLink to Molecular Medicine
. 1998 Jan;4(1):3–11.

Charcot-Marie-Tooth disease: lessons in genetic mechanisms.

J R Lupski 1
PMCID: PMC2230264  PMID: 9513184

Full text

PDF
5

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adlkofer K., Frei R., Neuberg D. H., Zielasek J., Toyka K. V., Suter U. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J Neurosci. 1997 Jun 15;17(12):4662–4671. doi: 10.1523/JNEUROSCI.17-12-04662.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adlkofer K., Martini R., Aguzzi A., Zielasek J., Toyka K. V., Suter U. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet. 1995 Nov;11(3):274–280. doi: 10.1038/ng1195-274. [DOI] [PubMed] [Google Scholar]
  3. Bird T. D., Ott J., Giblett E. R. Evidence for linkage of Charcot-Marie-Tooth neuropathy to the Duffy locus on chromosome 1. Am J Hum Genet. 1982 May;34(3):388–394. [PMC free article] [PubMed] [Google Scholar]
  4. Chance P. F., Abbas N., Lensch M. W., Pentao L., Roa B. B., Patel P. I., Lupski J. R. Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum Mol Genet. 1994 Feb;3(2):223–228. doi: 10.1093/hmg/3.2.223. [DOI] [PubMed] [Google Scholar]
  5. Chance P. F., Alderson M. K., Leppig K. A., Lensch M. W., Matsunami N., Smith B., Swanson P. D., Odelberg S. J., Disteche C. M., Bird T. D. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell. 1993 Jan 15;72(1):143–151. doi: 10.1016/0092-8674(93)90058-x. [DOI] [PubMed] [Google Scholar]
  6. Chance P. F., Bird T. D., Matsunami N., Lensch M. W., Brothman A. R., Feldman G. M. Trisomy 17p associated with Charcot-Marie-Tooth neuropathy type 1A phenotype: evidence for gene dosage as a mechanism in CMT1A. Neurology. 1992 Dec;42(12):2295–2299. doi: 10.1212/wnl.42.12.2295. [DOI] [PubMed] [Google Scholar]
  7. Chen K. S., Manian P., Koeuth T., Potocki L., Zhao Q., Chinault A. C., Lee C. C., Lupski J. R. Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome. Nat Genet. 1997 Oct;17(2):154–163. doi: 10.1038/ng1097-154. [DOI] [PubMed] [Google Scholar]
  8. Gal A., Mücke J., Theile H., Wieacker P. F., Ropers H. H., Wienker T. F. X-linked dominant Charcot-Marie-Tooth disease: suggestion of linkage with a cloned DNA sequence from the proximal Xq. Hum Genet. 1985;70(1):38–42. doi: 10.1007/BF00389456. [DOI] [PubMed] [Google Scholar]
  9. Grehl H., Rautenstrauss B., Liehr T., Bickel A., Ekici A., Bathke K., Neundörfer B. Clinical and morphological phenotype of HMSN 1A mosaicism. Neuromuscul Disord. 1997 Jan;7(1):27–31. doi: 10.1016/s0960-8966(96)00396-3. [DOI] [PubMed] [Google Scholar]
  10. Huxley C., Passage E., Manson A., Putzu G., Figarella-Branger D., Pellissier J. F., Fontés M. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet. 1996 May;5(5):563–569. doi: 10.1093/hmg/5.5.563. [DOI] [PubMed] [Google Scholar]
  11. Kaku D. A., Parry G. J., Malamut R., Lupski J. R., Garcia C. A. Nerve conduction studies in Charcot-Marie-Tooth polyneuropathy associated with a segmental duplication of chromosome 17. Neurology. 1993 Sep;43(9):1806–1808. doi: 10.1212/wnl.43.9.1806. [DOI] [PubMed] [Google Scholar]
  12. Killian J. M., Tiwari P. S., Jacobson S., Jackson R. D., Lupski J. R. Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy. Muscle Nerve. 1996 Jan;19(1):74–78. doi: 10.1002/(SICI)1097-4598(199601)19:1<74::AID-MUS10>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  13. Kiyosawa H., Chance P. F. Primate origin of the CMT1A-REP repeat and analysis of a putative transposon-associated recombinational hotspot. Hum Mol Genet. 1996 Jun;5(6):745–753. doi: 10.1093/hmg/5.6.745. [DOI] [PubMed] [Google Scholar]
  14. Lupski J. R. DNA diagnostics for Charcot-Marie-Tooth disease and related inherited neuropathies. Clin Chem. 1996 Jul;42(7):995–998. [PubMed] [Google Scholar]
  15. Lupski J. R., Roth J. R., Weinstock G. M. Chromosomal duplications in bacteria, fruit flies, and humans. Am J Hum Genet. 1996 Jan;58(1):21–27. [PMC free article] [PubMed] [Google Scholar]
  16. Lupski J. R., Wise C. A., Kuwano A., Pentao L., Parke J. T., Glaze D. G., Ledbetter D. H., Greenberg F., Patel P. I. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nat Genet. 1992 Apr;1(1):29–33. doi: 10.1038/ng0492-29. [DOI] [PubMed] [Google Scholar]
  17. Lupski J. R., de Oca-Luna R. M., Slaugenhaupt S., Pentao L., Guzzetta V., Trask B. J., Saucedo-Cardenas O., Barker D. F., Killian J. M., Garcia C. A. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 1991 Jul 26;66(2):219–232. doi: 10.1016/0092-8674(91)90613-4. [DOI] [PubMed] [Google Scholar]
  18. Magyar J. P., Martini R., Ruelicke T., Aguzzi A., Adlkofer K., Dembic Z., Zielasek J., Toyka K. V., Suter U. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci. 1996 Sep 1;16(17):5351–5360. doi: 10.1523/JNEUROSCI.16-17-05351.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Matsunami N., Smith B., Ballard L., Lensch M. W., Robertson M., Albertsen H., Hanemann C. O., Müller H. W., Bird T. D., White R. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat Genet. 1992 Jun;1(3):176–179. doi: 10.1038/ng0692-176. [DOI] [PubMed] [Google Scholar]
  20. Murakami T., Reiter L. T., Lupski J. R. Genomic structure and expression of the human heme A:farnesyltransferase (COX10) gene. Genomics. 1997 May 15;42(1):161–164. doi: 10.1006/geno.1997.4711. [DOI] [PubMed] [Google Scholar]
  21. Nelis E., Van Broeckhoven C., De Jonghe P., Löfgren A., Vandenberghe A., Latour P., Le Guern E., Brice A., Mostacciuolo M. L., Schiavon F. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet. 1996;4(1):25–33. doi: 10.1159/000472166. [DOI] [PubMed] [Google Scholar]
  22. Nicholson G. A., Valentijn L. J., Cherryson A. K., Kennerson M. L., Bragg T. L., DeKroon R. M., Ross D. A., Pollard J. D., McLeod J. G., Bolhuis P. A. A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. Nat Genet. 1994 Mar;6(3):263–266. doi: 10.1038/ng0394-263. [DOI] [PubMed] [Google Scholar]
  23. Patel P. I., Roa B. B., Welcher A. A., Schoener-Scott R., Trask B. J., Pentao L., Snipes G. J., Garcia C. A., Francke U., Shooter E. M. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet. 1992 Jun;1(3):159–165. doi: 10.1038/ng0692-159. [DOI] [PubMed] [Google Scholar]
  24. Pentao L., Wise C. A., Chinault A. C., Patel P. I., Lupski J. R. Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nat Genet. 1992 Dec;2(4):292–300. doi: 10.1038/ng1292-292. [DOI] [PubMed] [Google Scholar]
  25. Raeymaekers P., Timmerman V., Nelis E., De Jonghe P., Hoogendijk J. E., Baas F., Barker D. F., Martin J. J., De Visser M., Bolhuis P. A. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul Disord. 1991;1(2):93–97. doi: 10.1016/0960-8966(91)90055-w. [DOI] [PubMed] [Google Scholar]
  26. Reiter L. T., Murakami T., Koeuth T., Gibbs R. A., Lupski J. R. The human COX10 gene is disrupted during homologous recombination between the 24 kb proximal and distal CMT1A-REPs. Hum Mol Genet. 1997 Sep;6(9):1595–1603. doi: 10.1093/hmg/6.9.1595. [DOI] [PubMed] [Google Scholar]
  27. Reiter L. T., Murakami T., Koeuth T., Pentao L., Muzny D. M., Gibbs R. A., Lupski J. R. A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nat Genet. 1996 Mar;12(3):288–297. doi: 10.1038/ng0396-288. [DOI] [PubMed] [Google Scholar]
  28. Roa B. B., Dyck P. J., Marks H. G., Chance P. F., Lupski J. R. Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene. Nat Genet. 1993 Nov;5(3):269–273. doi: 10.1038/ng1193-269. [DOI] [PubMed] [Google Scholar]
  29. Roa B. B., Garcia C. A., Suter U., Kulpa D. A., Wise C. A., Mueller J., Welcher A. A., Snipes G. J., Shooter E. M., Patel P. I. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med. 1993 Jul 8;329(2):96–101. doi: 10.1056/NEJM199307083290205. [DOI] [PubMed] [Google Scholar]
  30. Roa B. B., Greenberg F., Gunaratne P., Sauer C. M., Lubinsky M. S., Kozma C., Meck J. M., Magenis R. E., Shaffer L. G., Lupski J. R. Duplication of the PMP22 gene in 17p partial trisomy patients with Charcot-Marie-Tooth type-1 neuropathy. Hum Genet. 1996 May;97(5):642–649. [PubMed] [Google Scholar]
  31. Sereda M., Griffiths I., Pühlhofer A., Stewart H., Rossner M. J., Zimmerman F., Magyar J. P., Schneider A., Hund E., Meinck H. M. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron. 1996 May;16(5):1049–1060. doi: 10.1016/s0896-6273(00)80128-2. [DOI] [PubMed] [Google Scholar]
  32. Shaffer L. G., Kennedy G. M., Spikes A. S., Lupski J. R. Diagnosis of CMT1A duplications and HNPP deletions by interphase FISH: implications for testing in the cytogenetics laboratory. Am J Med Genet. 1997 Mar 31;69(3):325–331. [PubMed] [Google Scholar]
  33. Shapiro L., Doyle J. P., Hensley P., Colman D. R., Hendrickson W. A. Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron. 1996 Sep;17(3):435–449. doi: 10.1016/s0896-6273(00)80176-2. [DOI] [PubMed] [Google Scholar]
  34. Smith A. C., McGavran L., Robinson J., Waldstein G., Macfarlane J., Zonona J., Reiss J., Lahr M., Allen L., Magenis E. Interstitial deletion of (17)(p11.2p11.2) in nine patients. Am J Med Genet. 1986 Jul;24(3):393–414. doi: 10.1002/ajmg.1320240303. [DOI] [PubMed] [Google Scholar]
  35. Suter U., Moskow J. J., Welcher A. A., Snipes G. J., Kosaras B., Sidman R. L., Buchberg A. M., Shooter E. M. A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4382–4386. doi: 10.1073/pnas.89.10.4382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Suter U., Welcher A. A., Ozcelik T., Snipes G. J., Kosaras B., Francke U., Billings-Gagliardi S., Sidman R. L., Shooter E. M. Trembler mouse carries a point mutation in a myelin gene. Nature. 1992 Mar 19;356(6366):241–244. doi: 10.1038/356241a0. [DOI] [PubMed] [Google Scholar]
  37. Timmerman V., Nelis E., Van Hul W., Nieuwenhuijsen B. W., Chen K. L., Wang S., Ben Othman K., Cullen B., Leach R. J., Hanemann C. O. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet. 1992 Jun;1(3):171–175. doi: 10.1038/ng0692-171. [DOI] [PubMed] [Google Scholar]
  38. Timmerman V., Rautenstrauss B., Reiter L. T., Koeuth T., Löfgren A., Liehr T., Nelis E., Bathke K. D., De Jonghe P., Grehl H. Detection of the CMT1A/HNPP recombination hotspot in unrelated patients of European descent. J Med Genet. 1997 Jan;34(1):43–49. doi: 10.1136/jmg.34.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Trask B. J., Mefford H., van den Engh G., Massa H. F., Juyal R. C., Potocki L., Finucane B., Abuelo D. N., Witt D. R., Magenis E. Quantification by flow cytometry of chromosome-17 deletions in Smith-Magenis syndrome patients. Hum Genet. 1996 Dec;98(6):710–718. doi: 10.1007/s004390050291. [DOI] [PubMed] [Google Scholar]
  40. Valentijn L. J., Baas F., Wolterman R. A., Hoogendijk J. E., van den Bosch N. H., Zorn I., Gabreëls-Festen A. W., de Visser M., Bolhuis P. A. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet. 1992 Dec;2(4):288–291. doi: 10.1038/ng1292-288. [DOI] [PubMed] [Google Scholar]
  41. Valentijn L. J., Bolhuis P. A., Zorn I., Hoogendijk J. E., van den Bosch N., Hensels G. W., Stanton V. P., Jr, Housman D. E., Fischbeck K. H., Ross D. A. The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nat Genet. 1992 Jun;1(3):166–170. doi: 10.1038/ng0692-166. [DOI] [PubMed] [Google Scholar]
  42. Vance J. M., Nicholson G. A., Yamaoka L. H., Stajich J., Stewart C. S., Speer M. C., Hung W. Y., Roses A. D., Barker D., Pericak-Vance M. A. Linkage of Charcot-Marie-Tooth neuropathy type 1a to chromosome 17. Exp Neurol. 1989 May;104(2):186–189. doi: 10.1016/s0014-4886(89)80013-5. [DOI] [PubMed] [Google Scholar]
  43. Warner L. E., Hilz M. J., Appel S. H., Killian J. M., Kolodry E. H., Karpati G., Carpenter S., Watters G. V., Wheeler C., Witt D. Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron. 1996 Sep;17(3):451–460. doi: 10.1016/s0896-6273(00)80177-4. [DOI] [PubMed] [Google Scholar]
  44. Warner L. E., Reiter L. T., Murakami T., Lupski J. R. Molecular mechanisms for Charcot-Marie-Tooth disease and related demyelinating peripheral neuropathies. Cold Spring Harb Symp Quant Biol. 1996;61:659–671. [PubMed] [Google Scholar]
  45. Warner L. E., Roa B. B., Lupski J. R. Absence of PMP22 coding region mutations in CMT1A duplication patients: further evidence supporting gene dosage as a mechanism for Charcot-Marie-Tooth disease type 1A. Hum Mutat. 1996;8(4):362–365. doi: 10.1002/(SICI)1098-1004(1996)8:4<362::AID-HUMU10>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  46. Yoshikawa H., Nishimura T., Nakatsuji Y., Fujimura H., Himoro M., Hayasaka K., Sakoda S., Yanagihara T. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann Neurol. 1994 Apr;35(4):445–450. doi: 10.1002/ana.410350412. [DOI] [PubMed] [Google Scholar]
  47. Young P., Wiebusch H., Stögbauer F., Ringelstein B., Assmann G., Funke H. A novel frameshift mutation in PMP22 accounts for hereditary neuropathy with liability to pressure palsies. Neurology. 1997 Feb;48(2):450–452. doi: 10.1212/wnl.48.2.450. [DOI] [PubMed] [Google Scholar]
  48. Zori R. T., Lupski J. R., Heju Z., Greenberg F., Killian J. M., Gray B. A., Driscoll D. J., Patel P. I., Zackowski J. L. Clinical, cytogenetic, and molecular evidence for an infant with Smith-Magenis syndrome born from a mother having a mosaic 17p11.2p12 deletion. Am J Med Genet. 1993 Sep 15;47(4):504–511. doi: 10.1002/ajmg.1320470414. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ

RESOURCES